# MoonLake Immunotherapeutics: Form SCHEDULE 13D/A, filed Apr 2, 2026

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 16:44 ET
- Period: not reported
- Accession: 0000921895-26-000894
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000092189526000894/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000092189526000894/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000092189526000894/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0000921895-26-000894. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.